VP, Market Access, Value & Evidence
Mike leads Market Access, Value & Evidence on behalf of Pear Therapeutics. Prior to joining Pear, he was a Divisional Principal with ICON plc, where he led the firm’s Value Strategy Consulting practice and Global Pricing & Market Access team in the US and Europe. In previous roles with EMD Serono, Sanofi, Allergan, OM1, and Beansprout Networks, Mike orchestrated strategy and led commercial functions including business development, product development and commercialization strategy, market access and reimbursement strategy, payer and specialty account management, contracts and pricing, operations and analytics, sales, sales training and leadership development.
Mike led a team that conceived and launched the hallmark biotech industry reference, EMD Serono Specialty Digest™, in addition to pioneering the implementation of the first ever outcomes-based agreements for a specialty biologic with a health plan, and then with a PBM, in the United States. Subsequently, Mike has actualized dozens of outcomes and value-based payer arrangements between digital health, biopharma, payer and technology value chain stakeholders. He has been a leading innovator, global advisor, author, thought leader and trusted catalyst in the field since 2009, orchestrating market access and innovative go-to-market models for some of the world’s most cutting-edge technologies and novel therapeutics.
Mike earned his BSBA in Finance and Banking from the University of Missouri-Columbia, where he was a distance freestyler and Co-Captain of the Men’s Swimming Team, and his MBA in Entrepreneurship and Marketing from the FW Olin Graduate School of Business at Babson College.